Literature DB >> 28814118

Considerations for clinical trial design in older adults with cancer.

Enrique Soto-Perez-De-Celis1,2, Stuart M Lichtman3.   

Abstract

Entities:  

Keywords:  Older adults; clinical trials as topic; evidence-based medicine; geriatric assessment; investigative techniques

Mesh：

Year:  2017        PMID： 28814118      PMCID： PMC6080715          DOI： 10.1080/13543784.2017.1369043

Source DB:  PubMed          Journal:  Expert Opin Investig Drugs        ISSN： 1354-3784            Impact factor:   6.206


× No keyword cloud information.
  17 in total

1.  Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG oncology/Gynecologic Oncology Group study.

Authors:  Vivian E von Gruenigen; Helen Q Huang; Jan H Beumer; Heather A Lankes; William Tew; Thomas Herzog; Arti Hurria; Robert S Mannel; Tina Rizack; Lisa M Landrum; Peter G Rose; Ritu Salani; William H Bradley; Thomas J Rutherford; Robert V Higgins; Angeles Alvarez Secord; Gini Fleming
Journal:  Gynecol Oncol       Date:  2017-01-13       Impact factor: 5.482

2.  Time to Stop Saying Geriatric Assessment Is Too Time Consuming.

Authors:  Marije E Hamaker; Tanya M Wildes; Siri Rostoft
Journal:  J Clin Oncol       Date:  2017-06-19       Impact factor: 44.544

3.  Effect of Pretreatment Renal Function on Treatment and Clinical Outcomes in the Adjuvant Treatment of Older Women With Breast Cancer: Alliance A171201, an Ancillary Study of CALGB/CTSU 49907.

Authors:  Stuart M Lichtman; Constance T Cirrincione; Arti Hurria; Aminah Jatoi; Maria Theodoulou; Antonio C Wolff; Julie Gralow; Daniel E Morganstern; Gustav Magrinat; Harvey Jay Cohen; Hyman B Muss
Journal:  J Clin Oncol       Date:  2016-01-11       Impact factor: 44.544

4.  Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401.

Authors:  Arti Hurria; Constance T Cirrincione; Hyman B Muss; Alice B Kornblith; William Barry; Andrew S Artz; Linda Schmieder; Rafat Ansari; William P Tew; Douglas Weckstein; Jeffrey Kirshner; Kayo Togawa; Kurt Hansen; Vani Katheria; Richard Stone; Ilene Galinsky; John Postiglione; Harvey Jay Cohen
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

5.  Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.

Authors:  Alice B Kornblith; Lan Lan; Laura Archer; Ann Partridge; Gretchen Kimmick; Clifford Hudis; Eric Winer; Rebecca Casey; Samantha Bennett; Harvey Jay Cohen; Hyman B Muss
Journal:  J Clin Oncol       Date:  2011-02-07       Impact factor: 44.544

6.  Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement.

Authors:  Arti Hurria; Laura A Levit; William Dale; Supriya G Mohile; Hyman B Muss; Louis Fehrenbacher; Allison Magnuson; Stuart M Lichtman; Suanna S Bruinooge; Enrique Soto-Perez-de-Celis; William P Tew; Michael A Postow; Harvey J Cohen
Journal:  J Clin Oncol       Date:  2015-07-20       Impact factor: 44.544

Review 7.  Pragmatic study designs for older adults with cancer: Report from the U13 conference.

Authors:  Ryan D Nipp; Nengliang Aaron Yao; Lisa M Lowenstein; Jan C Buckner; Ira R Parker; Ajeet Gajra; Vicki A Morrison; William Dale; Karla V Ballman
Journal:  J Geriatr Oncol       Date:  2016-07-05       Impact factor: 3.599

8.  Validation of a Prediction Tool for Chemotherapy Toxicity in Older Adults With Cancer.

Authors:  Arti Hurria; Supriya Mohile; Ajeet Gajra; Heidi Klepin; Hyman Muss; Andrew Chapman; Tao Feng; David Smith; Can-Lan Sun; Nienke De Glas; Harvey Jay Cohen; Vani Katheria; Caroline Doan; Laura Zavala; Abrahm Levi; Chie Akiba; William P Tew
Journal:  J Clin Oncol       Date:  2016-05-16       Impact factor: 44.544

9.  Adjuvant chemotherapy in older women with early-stage breast cancer.

Authors:  Hyman B Muss; Donald A Berry; Constance T Cirrincione; Maria Theodoulou; Ann M Mauer; Alice B Kornblith; Ann H Partridge; Lynn G Dressler; Harvey J Cohen; Heather P Becker; Patricia A Kartcheske; Judith D Wheeler; Edith A Perez; Antonio C Wolff; Julie R Gralow; Harold J Burstein; Ahmad A Mahmood; Gustav Magrinat; Gutav Magrinat; Barbara A Parker; Ronald D Hart; Debjani Grenier; Larry Norton; Clifford A Hudis; Eric P Winer
Journal:  N Engl J Med       Date:  2009-05-14       Impact factor: 91.245

10.  Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial.

Authors:  Matthew T Seymour; Lindsay C Thompson; Harpreet S Wasan; Gary Middleton; Alison E Brewster; Stephen F Shepherd; M Sinead O'Mahony; Timothy S Maughan; Mahesh Parmar; Ruth E Langley
Journal:  Lancet       Date:  2011-05-11       Impact factor: 79.321
View more
  10 in total

1.  Changes in the Use of Comprehensive Geriatric Assessment in Clinical Trials for Older Patients with Cancer over Time.

Authors:  Olivia Le Saux; Claire Falandry; Hui K Gan; Benoit You; Gilles Freyer; Julien Péron
Journal:  Oncologist       Date:  2019-02-01

2.  The underreporting of phase III chemo-therapeutic clinical trial data of older patients with cancer: A systematic review.

Authors:  Karlynn BrintzenhofeSzoc; Jessica L Krok-Schoen; Beverly Canin; Ira Parker; Amy R MacKenzie; Thuy Koll; Ritika Vankina; Christine D Hsu; Brian Jang; Kathy Pan; Jennifer L Lund; Edith Starbuck; Armin Shahrokni
Journal:  J Geriatr Oncol       Date:  2020-01-10       Impact factor: 3.599

Review 3.  All-Cause Mortality Risk Prediction in Older Adults with Cancer: Practical Approaches and Limitations.

Authors:  Andrea Perez-de-Acha; Sophie Pilleron; Enrique Soto-Perez-de-Celis
Journal:  Curr Oncol Rep       Date:  2022-06-01       Impact factor: 5.075

Review 4.  Non-stereotactic radiotherapy in older cancer patients.

Authors:  Silvana Parisi; Sara Lillo; Alberto Cacciola; Gianluca Ferini; Vito Valenti; Anna Viola; Anna Santacaterina; Angelo Platania; Anna Brogna; Consuelo Tamburella; Stefano Pergolizzi
Journal:  Heliyon       Date:  2022-05-31

Review 5.  Current Challenges Faced by Cancer Clinical Trials in Addressing the Problem of Under-Representation of Older Adults: A Narrative Review.

Authors:  Ruth M Parks; Holly M Holmes; Kwok-Leung Cheung
Journal:  Oncol Ther       Date:  2021-01-22

Review 6.  Challenges in Geriatric Oncology-A Surgeon's Perspective.

Authors:  Ruth Parks; Kwok-Leung Cheung
Journal:  Curr Oncol       Date:  2022-01-29       Impact factor: 3.677

7.  Decision-making about clinical trial options among older patients with metastatic cancer who have exhausted standard therapies.

Authors:  Mazie Tsang; Rebecca J DeBoer; Sarah B Garrett; Daniel Dohan
Journal:  J Geriatr Oncol       Date:  2022-02-04       Impact factor: 3.929

8.  Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: an age-specific subgroup analysis of MONARCH 2 and 3 trials.

Authors:  Matthew P Goetz; Meena Okera; Hans Wildiers; Mario Campone; Eva-Maria Grischke; Luis Manso; Valérie A M André; Nadia Chouaki; Belén San Antonio; Masakazu Toi; George W Sledge
Journal:  Breast Cancer Res Treat       Date:  2021-01-03       Impact factor: 4.872

9.  Age Is Just a Number: Considerations for Older Adults in Cancer Clinical Trials.

Authors:  Dany Habr; Lynn McRoy; Vassiliki A Papadimitrakopoulou
Journal:  J Natl Cancer Inst       Date:  2021-11-02       Impact factor: 13.506

10.  Prevalence of and factors associated with treatment modification at first cycle in older adults with advanced cancer receiving palliative treatment.

Authors:  Mostafa R Mohamed; Kaitlin Kyi; Supriya G Mohile; Huiwen Xu; Eva Culakova; Kah Poh Loh; Marie Flannery; Spencer Obrecht; Erika Ramsdale; Amita Patil; Richard F Dunne; Grace DiGiovanni; Aram Hezel; Brian Burnette; Nisarg Desai; Jeffrey Giguere; Allison Magnuson
Journal:  J Geriatr Oncol       Date:  2021-07-14       Impact factor: 3.929
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.